ATE302016T1 - Peptide, verwendet als träger in immunogenen konstrukten, die in der entwicklung synthetischer impfstoffe geeignet sind - Google Patents
Peptide, verwendet als träger in immunogenen konstrukten, die in der entwicklung synthetischer impfstoffe geeignet sindInfo
- Publication number
- ATE302016T1 ATE302016T1 AT95920641T AT95920641T ATE302016T1 AT E302016 T1 ATE302016 T1 AT E302016T1 AT 95920641 T AT95920641 T AT 95920641T AT 95920641 T AT95920641 T AT 95920641T AT E302016 T1 ATE302016 T1 AT E302016T1
- Authority
- AT
- Austria
- Prior art keywords
- carriers
- development
- peptides used
- constructs useful
- synthetic vaccines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
- C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6043—Heat shock proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL10979094A IL109790A0 (en) | 1994-05-25 | 1994-05-25 | Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines |
PCT/US1995/006575 WO1995031994A1 (en) | 1994-05-25 | 1995-05-24 | Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE302016T1 true ATE302016T1 (de) | 2005-09-15 |
Family
ID=11066168
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95920641T ATE302016T1 (de) | 1994-05-25 | 1995-05-24 | Peptide, verwendet als träger in immunogenen konstrukten, die in der entwicklung synthetischer impfstoffe geeignet sind |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0760671B1 (de) |
JP (1) | JPH10504524A (de) |
AT (1) | ATE302016T1 (de) |
AU (1) | AU684369B2 (de) |
CA (1) | CA2191202A1 (de) |
DE (1) | DE69534382T2 (de) |
IL (1) | IL109790A0 (de) |
WO (1) | WO1995031994A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0700445T3 (da) | 1993-06-04 | 2002-05-13 | Whitehead Biomedical Inst | Stressproteiner og anvendelser deraf |
US7157089B1 (en) | 1996-11-26 | 2007-01-02 | Stressgen Biotechnologies Corporation | Immune responses using compositions containing stress proteins |
WO1998035705A1 (en) * | 1997-02-18 | 1998-08-20 | Whitehead Institute For Biomedical Research | Use of heat shock proteins to deliver moieties into cells |
ATE231917T1 (de) | 1997-08-05 | 2003-02-15 | Stressgen Biotechnologies Corp | Immunresponse gegen hpv antigene erregt von zusammensetzungen die ein hpv antigen und ein stressprotein enthalten oder einen expressionsvektor fähig zur expression dieser proteine |
DE19821859A1 (de) * | 1998-05-15 | 1999-12-09 | M Alexander Schmidt | Darstellung immunogener (Kapsel-)Polysaccharid-Konjugate durch orientierte Kupplung synthetischer T-Zell-Epitope zur Erzeugung von Vakzinen gegen N.meningitidis |
US6197340B1 (en) | 1998-05-28 | 2001-03-06 | Medical Research Institute | Controlled release lipoic acid |
CN1367875A (zh) * | 1999-07-08 | 2002-09-04 | 斯特思吉生物技术公司 | 活体外th1一样反应的诱导方法 |
US6677139B1 (en) | 1999-12-23 | 2004-01-13 | Genecor International, Inc. | Methods for production of proteins in host cells |
ATE438408T1 (de) | 2000-01-14 | 2009-08-15 | Whitehead Biomedical Inst | Induktion zytotoxischer lymphozyten durch hitzeschockprotein-fusionsproteine hängt von der atp-bindungsdomäne in hsp ab und is cd4+ unabhängig |
CN100441223C (zh) | 2000-06-26 | 2008-12-10 | 尼文塔生物制药公司 | 人乳头状瘤病毒治疗 |
IT1319277B1 (it) * | 2000-10-24 | 2003-09-26 | Chiesi Farma Spa | Proteine di fusione utili per il trattamento di immunizzazione dellamalattia di alzheimer. |
MXPA03006971A (es) | 2001-02-05 | 2004-05-05 | Stressgen Biotechnologies Corp | Tratamiento del virus de hepatitis b. |
AUPR852301A0 (en) * | 2001-10-26 | 2001-11-29 | Medvet Science Pty. Ltd. | Groel chimeric protein and vaccine |
WO2006097914A2 (en) * | 2005-03-14 | 2006-09-21 | Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science | Compositions of hsp60 peptides and viral antigens for vaccination and diagnosis |
EP2870974A1 (de) | 2013-11-08 | 2015-05-13 | Novartis AG | Salmonella-Konjugatimpfstoffe |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1262896B (it) * | 1992-03-06 | 1996-07-22 | Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini. | |
IL102687A (en) * | 1992-07-30 | 1997-06-10 | Yeda Res & Dev | Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them |
-
1994
- 1994-05-25 IL IL10979094A patent/IL109790A0/xx not_active IP Right Cessation
-
1995
- 1995-05-24 AT AT95920641T patent/ATE302016T1/de not_active IP Right Cessation
- 1995-05-24 CA CA002191202A patent/CA2191202A1/en not_active Abandoned
- 1995-05-24 AU AU26027/95A patent/AU684369B2/en not_active Ceased
- 1995-05-24 DE DE69534382T patent/DE69534382T2/de not_active Expired - Lifetime
- 1995-05-24 EP EP95920641A patent/EP0760671B1/de not_active Expired - Lifetime
- 1995-05-24 WO PCT/US1995/006575 patent/WO1995031994A1/en active IP Right Grant
- 1995-05-24 JP JP7530530A patent/JPH10504524A/ja not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
DE69534382D1 (de) | 2005-09-22 |
WO1995031994A1 (en) | 1995-11-30 |
IL109790A0 (en) | 1994-08-26 |
CA2191202A1 (en) | 1995-11-30 |
AU2602795A (en) | 1995-12-18 |
EP0760671A4 (de) | 1999-11-17 |
EP0760671B1 (de) | 2005-08-17 |
JPH10504524A (ja) | 1998-05-06 |
AU684369B2 (en) | 1997-12-11 |
EP0760671A1 (de) | 1997-03-12 |
DE69534382T2 (de) | 2006-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9306820A (pt) | Conjugado de um antígeno fracamente imunogênico e um veículo peptideo sintetico vacina processos para melhorar a imunogenicidade de uma molecula de antigeno fracamente imunogenico e para imunizar um hospedeiro mamífero | |
ATE302016T1 (de) | Peptide, verwendet als träger in immunogenen konstrukten, die in der entwicklung synthetischer impfstoffe geeignet sind | |
DE69111801D1 (de) | Vakzin gegen hepatitis b. | |
DE69839587D1 (de) | Enterokokkus antigene und vakzine | |
DK174416B1 (da) | Oligopeptider, immunogene konjugater heraf med et antigen samt vacciner indeholdende disse konjugater | |
WO1995029193A3 (en) | Melanoma antigens | |
NZ296564A (en) | Method of improving antigenicity of antigens or haptens, fusion with rsv peptides; vaccines, vectors, nucleotides | |
AU3234295A (en) | Influenza virus subunit conjugates | |
DE69419966D1 (de) | Impstoff gegen Streptococcus suis-Infektion | |
WO1999013907A3 (en) | Methods to improve immunogenicity of antigens and specificity of antibodies | |
AU3193897A (en) | Vaccine comprising antigens bound to carriers through labile bonds | |
ATE221786T1 (de) | Synthetischer impfstoff zum schutz gegen infektionen mit dem menschlichen immunschwächevirus | |
GB2314560A (en) | Synthetic peptides of m. gallisepticum, antibodies thereto, their preparations and use | |
Mulyadi et al. | IMMUNOGENICITY AND PROTECTIVITY OF THE OUTER MEMBRANE PROTEIN BANDS OF PASTEURELLA MULTOCIDA ISOLATE U-6 | |
ES1027961U (es) | Soporte publicitario para carritos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |